BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36585228)

  • 1. [N
    Wang J; Zhao X; Lu Y; Fan D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Dec; 38(12):1069-1077. PubMed ID: 36585228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 5. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
    Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors.
    Li M; Li S; Zhou L; Yang L; Wu X; Tang B; Xie S; Fang L; Zheng S; Hong T
    Front Oncol; 2021; 11():717606. PubMed ID: 34604053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma.
    Wei S; Lu K; Xing J; Yu W
    FASEB J; 2023 Apr; 37(4):e22849. PubMed ID: 36884358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer.
    Yu J; Zhang Q; Wang M; Liang S; Huang H; Xie L; Cui C; Yu J
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33492335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
    Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
    Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
    [No Abstract]   [Full Text] [Related]  

  • 11. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
    Zhang J; Wang K; Hainisayimu T; Li H
    Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value and Immunological Role of MORF4-Related Gene-Binding Protein in Human Cancers.
    Chai D; Zhang L; Guan Y; Yuan J; Li M; Wang W
    Front Cell Dev Biol; 2021; 9():703415. PubMed ID: 34660575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
    Chen X; Jiang Z; Wang Z; Jiang Z
    Aging (Albany NY); 2021 May; 13(9):12849-12864. PubMed ID: 33946045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.
    Zeng Y; Zhang X; Li F; Wang Y; Wei M
    J Clin Lab Anal; 2022 Jun; 36(6):e24437. PubMed ID: 35478418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
    Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
    Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.
    Wen J; Mao X; Cheng Q; Liu Z; Liu F
    Sci Rep; 2021 Nov; 11(1):22502. PubMed ID: 34795387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
    Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
    Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer.
    Lin K; Wang Y; Liu F; You T; Liu X; Liu R; Li Z; Zhen C; Zhang Y; Liu X; Cai H
    Eur J Med Res; 2024 Mar; 29(1):206. PubMed ID: 38539263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

  • 20. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.